Severe Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent Patients
Steven T. Bird(Brigham and Women's Hospital), David J. Graham(United States Food and Drug Administration), Henu Zhao(Acumen (United States)), Kate Gelperin(United States Food and Drug Administration), Michael Wernecke(Acumen (United States)), Olivia Easley(United States Food and Drug Administration), Hai Lyu(Acumen (United States)), Marina Zemskova(United States Food and Drug Administration), Tae Hyun Jung(United States Food and Drug Administration), Yoganand Chillarige(Acumen (United States)), Rekha Kambhampati(United States Food and Drug Administration), Yunfan Zhu(Acumen (United States)), Elizabeth R. Smith(University of Miami), Aliza Thompson(United States Food and Drug Administration), Ali Niak(United States Food and Drug Administration), Jeffrey A. Kelman(Centers for Medicare and Medicaid Services), Yueqin Zhao(United States Food and Drug Administration)
Cited by 76
Related Papers
Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium
|Nature Biotechnology|2010|406
Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis
|Canadian Medical Association Journal|2012|120
Isotretinoin and Risk for Inflammatory Bowel Disease
|JAMA Dermatology|2013|93
Risk of acute kidney injury associated with the use of fluoroquinolones
|Canadian Medical Association Journal|2013|89